How Is Breast Cancer Diagnosed? From Exam to Staging

Breast cancer diagnosis typically follows a step-by-step process: a clinical exam, imaging (usually a mammogram and often an ultrasound), and then a biopsy to confirm whether cancer is present. The entire sequence can take anywhere from a few days to a few weeks, depending on how quickly each test is scheduled and how soon results come back. Here’s what each step involves and what you can expect.

The Clinical Breast Exam

The process usually starts with a physical examination. With you sitting upright, a doctor visually inspects both breasts for asymmetry, skin changes like dimpling or inflammation, nipple discharge, and any obvious masses. They then feel the breast tissue and the lymph nodes under your arms and along your collarbone.

What the doctor feels matters. Benign lumps tend to be smooth, soft to firm, and movable, with well-defined edges. A lump that raises concern for cancer is typically hard, immobile, and feels fixed to the surrounding skin or tissue, with irregular or poorly defined margins. Skin changes like thickening, redness, or a texture that looks like orange peel can also signal something that needs further workup. None of these findings alone confirm cancer, but they help determine what imaging to order next.

Mammography and Other Imaging

If something suspicious is found on exam, or if a routine screening mammogram shows an abnormality, the next step is usually a diagnostic mammogram. Unlike a screening mammogram (which takes standard images of each breast), a diagnostic mammogram focuses on a specific area with additional views and magnification to get a closer look at whatever caught attention.

Standard 2D mammography catches most breast cancers, with sensitivity approaching 90% in women whose breast tissue isn’t particularly dense. But breast density makes a significant difference. In women with extremely dense tissue, mammography sensitivity can drop to as low as 30%. Since women with dense or heterogeneously dense breasts make up roughly half of screening-age women in the U.S., this is a real limitation.

3D mammography (digital breast tomosynthesis) has improved on these numbers. Compared to standard 2D mammograms, 3D imaging detects about 29% more cancers overall and 44% more invasive cancers. It also reduces false alarms: the callback rate drops by about 16%, and when a callback does happen, it’s more likely to reflect an actual finding. Many screening centers now use 3D mammography as their default.

Ultrasound and MRI

Ultrasound is frequently used alongside mammography, especially to evaluate a lump that showed up on a mammogram or was felt during an exam. It’s particularly useful for distinguishing fluid-filled cysts (almost always benign) from solid masses that may need a biopsy. For women with dense breast tissue, ultrasound can pick up cancers that mammograms miss.

Breast MRI is reserved for specific situations: women at very high risk due to genetics or family history, cases where the extent of a known cancer needs to be mapped before surgery, or when mammography and ultrasound haven’t given a clear answer. MRI is highly sensitive but also flags many benign findings, so it’s not used as a first-line screening tool for most women.

Biopsy: The Only Way to Confirm Cancer

Imaging can show that something looks suspicious, but only a biopsy can confirm whether cancer cells are actually present. A small sample of tissue is removed and examined under a microscope by a pathologist. There are several types, and which one you get depends on the size, location, and characteristics of the abnormality.

Fine-needle aspiration uses a very thin needle to withdraw cells or fluid. It’s quick and causes minimal discomfort. If the lump turns out to be a fluid-filled cyst, this may resolve the issue entirely. For solid masses, it can provide preliminary information but often isn’t enough for a definitive diagnosis.

Core needle biopsy is the most common method for diagnosing breast cancer. A slightly larger needle, often guided by ultrasound, removes small cylinders of tissue. The needle is spring-loaded and “fired” into the tissue to capture the sample. This gives the pathologist enough material to determine not just whether cancer is present, but also the cancer’s type and key biological features.

Vacuum-assisted biopsy uses a probe (typically guided by imaging) that draws tissue into the needle with suction. It collects larger and more contiguous samples than a standard core needle biopsy, which makes it especially useful for areas of calcification that may be spread across a wider zone of tissue. The probe is manually inserted rather than fired, which can be preferable for lesions deep in the breast because it reduces the risk of the needle going too far. Vacuum-assisted biopsies also result in fewer cases where a repeat biopsy is needed.

Surgical biopsy removes part or all of a suspicious lump through a small incision. It’s less common now that needle biopsies are so reliable, but it’s still used when needle biopsies are inconclusive or when the abnormality is difficult to reach.

What Recovery Looks Like

Recovery depends on the type of biopsy. After fine-needle aspiration, the area may be sore, and you’ll want to take it easy for the rest of the day, but most people return to normal activities the next morning. Core needle biopsy typically comes with a recommendation to avoid strenuous activity for at least two days. Surgical biopsy involves more downtime: pain at the site can last several days, and it may take up to a week before you feel ready to resume your regular routine.

Bruising and mild swelling at the biopsy site are normal with any method. Your care team will give you specific instructions about wound care and when to remove any bandages.

What the Pathology Report Reveals

The biopsy tissue goes to a lab where a pathologist examines it and produces a report. This report does more than say “cancer” or “not cancer.” If cancer is found, it identifies the type (ductal, lobular, or a rarer form), the grade (how abnormal the cells look, which signals how aggressively the cancer is likely to behave), and whether the cells have receptors for estrogen, progesterone, or a protein called HER2. These receptor results directly shape which treatments will be most effective.

Staging: Determining How Far It Has Spread

Once cancer is confirmed, staging determines its size and whether it has reached lymph nodes or other parts of the body. Doctors use a system based on three factors: the tumor size (T), lymph node involvement (N), and whether there are distant metastases (M).

Tumor size categories are straightforward. A tumor 20 millimeters or smaller is classified as T1. Between 20 and 50 millimeters is T2. Larger than 50 millimeters is T3. T4 means the tumor has grown into the chest wall or skin, or the cancer is the inflammatory type.

Lymph node status is assessed either by imaging or, more definitively, by removing one or more nodes during surgery. N0 means no cancer in the nodes. N1 means cancer in one to three underarm nodes. N2 means four to nine nodes are involved. N3 means ten or more nodes, or spread to nodes near the collarbone.

For early-stage cancers (stage I), full-body imaging scans aren’t typically needed because the likelihood of distant spread is very low. Starting at stage IIB, when the tumor is larger or lymph nodes are involved, doctors generally recommend a PET/CT scan or similar imaging to check for metastases in the bones, lungs, liver, or other organs. In stage IV disease, where cancer has already spread, PET/CT helps map the precise extent of metastatic disease so the treatment plan can be tailored accordingly.

How Long the Whole Process Takes

The timeline from first suspicion to confirmed diagnosis varies. If you’re called back after a screening mammogram, the diagnostic mammogram and ultrasound can sometimes happen the same day or within a week. A biopsy is usually scheduled within days of an abnormal imaging result. Pathology results from a biopsy typically take several business days to a week, though some complex analyses (like genetic profiling of the tumor) can take longer. From that first callback to a clear answer, most people are looking at roughly one to three weeks, though the waiting can feel much longer than the actual procedures.